The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study단일 의료 시스템에서 의료 종사자들 사이에서 BNT162b2 백신 접종 후 SARS-CoV-2 스파이크 단백질에 대한 부작용과 면역 반응 사이의 연관성: 전향적 관찰 코호트 연구Observational Study Published on 2022-11-302022-09-12 Journal: Human vaccines & immunotherapeutics [Category] MERS, SARS, 임상, 진단, [키워드] administration Adverse Adverse reaction Anti-spike IgG antibody anti-spike IgG level Antibody titer association Asthma BNT162b2 BNT162b2 vaccine conducted COVID-19 Cutoff determine Factor first dose healthcare healthcare worker help humoral humoral immune response Humoral response IgG IgG level immune response information Local majority median median age mRNA mRNA vaccine of BNT162b2 participant Participants prospective observational cohort reaction recipients recruited reported SARS-CoV-2 anti-spike IgG SARS-CoV-2 spike protein second dose significantly higher systemic adverse reactions Systemic adverse reactions. systemic reaction vaccination Vaccine was collected were measured with COVID-19 women [DOI] 10.1080/21645515.2022.2048559 PMC 바로가기 [Article Type] Observational Study
Societal activities associated with SARS-CoV-2 infection: a case-control study in Denmark, November 2020Transformations Published on 2022-11-172022-11-01 Journal: Epidemiology and Infection [Category] COVID-19, MERS, [키워드] 95% CI 95% confidence interval activity age alcohol case-control study close contact Community Community acquired infections conducted Contact Control controls country COVID-19 Denmark determinant determinants disease event Evidence household size identification Infection investigated National Odds ratio Other Participants performed positive preventive measures reduce Risk factors RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections Sex telephone tested took place Transmission Transport Travel [DOI] 10.1017/S0950268821002478 PMC 바로가기 [Article Type] Transformations
IgG-RBD Response Due to Inactivated SARS-CoV-2 Vaccine: Alteration in D-Dimer and Fibrinogen Concentrations, Association with Comorbidities and Adverse EffectsArticle Published on 2022-11-032022-11-15 Journal: Laboratory medicine [Category] SARS, 진단, [키워드] Adverse alteration appear blood sample both groups changes in Concentration CoronaVac Coronavirus infection COVID-19 COVID-19 infection D-dimer D-dimer level domain Effect effective fibrinogen fibrinogen level first vaccination IgG Immunoglobulin individual infected individual Infection Mask Measures Participants Protective response Safe SARS-CoV-2 second dose second vaccination Side effects significantly higher statistically subject vaccination vaccination. Vaccine was obtained were measured [DOI] 10.1093/labmed/lmac047 PMC 바로가기
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 ConditionsArticle Published on 2022-11-012022-11-16 Journal: JAMA Psychiatry [Category] SARS, 유전자 메커니즘, [키워드] 95% CI adjusted age Anxiety baseline characterized Comorbidities condition COVID COVID-19 COVID-19 symptom COVID-19-related symptom Depression determine distress female Final Follow-up Future Health health care workers highest impairment increased risk individual Infection loneliness long-lasting lowest mechanism Nurse outcome pandemic participant Participants Perceived Perceived stress positive Postinfection prospective cohort study Psychological distress questionnaire Questionnaires reported returned risk risk factor SARS-COV-2 infection SARS-CoV-2 test sociodemographic factors Symptoms the mean these symptom used data were measured Worry [DOI] 10.1001/jamapsychiatry.2022.2640 PMC 바로가기
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trialArticle Published on 2022-11-012022-11-15 Journal: Immunology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 95% confidence interval Administered adverse event approved assessment booster booster dose booster vaccination clinical trials Course COVID-19 COVID-19 vaccination COVID-19 vaccine cross-neutralization cross-neutralization. Day double-blind Effect fatigue Heterologous homologous humoral immunogenic immunogenicity incidence injection site pain Local Neutralizing antibodies neutralizing antibody outcome participant Participants Placebo placebo-controlled primary immunogenicity Randomized randomized placebo-controlled trial Recombinant spike protein reported robust Safe Safety safety profile saline placebo SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 variants Serious Adverse Event Serious Adverse Events Seroconversion seroconversion rate shown SpikoGen subunit the placebo group Trial Vaccine was performed [DOI] 10.1111/imm.13540 PMC 바로가기
Summarising data and factors associated with COVID-19 related conspiracy theories in the first year of the pandemic: a systematic review and narrative synthesisArticle Published on 2022-11-012022-11-15 Journal: BMC Psychology [Category] SARS, 치료기술, [키워드] age beliefs carried Consequences Conspiracy theories COVID-19 detect determinant Effect Factor female gender First year Government Health health-related behaviour Health-related behaviours healthcare identify infodemic information media misinformation organization outbreak pandemic participant Participants Prevalence Psychological PsycINFO Public public health public health threat public health. Sociodemographic factor Spread systematic review with COVID-19 [DOI] 10.1186/s40359-022-00959-6 PMC 바로가기
Attitude toward COVID-19 vaccines and its association with depressive symptoms in 386,924 Chinese primary school students during COVID-19 epidemic normalizationResearch article Published on 2022-11-012022-10-05 Journal: Journal of psychosomatic research [Category] 변종, [키워드] 95% confidence interval addition adjusted odds ratio Analysis association Attitude children China Chinese Cluster COVID-19 COVID-19 epidemic COVID-19 infection COVID-19 vaccine COVID-19 vaccines cross-sectional depressive symptom Depressive symptoms evaluate evaluated Factor Government information inventory involved lower risk multiple logistic regression Participants positive attitude Prevalence promote PROTECT reliability Result Safe School the vaccine vaccination Vaccine was used were used [DOI] 10.1016/j.jpsychores.2022.111021 [Article Type] Research article
How the COVID-19 pandemic divides society: Towards a better understanding of differences between supporters and opponents of the COVID-19 pandemic lockdown in GermanyArticle Published on 2022-11-012022-11-16 Journal: Journal of psychiatric research [Category] SARS, 치료기술, [키워드] aggression Anxiety approach Containment measure containment measures Corona Corona lockdown opponents coronavirus COVID-19 COVID-19 pandemic cross-sectional demonstrated Depression depressive symptom Effect Factor GAD-7 Germany Health identify increase in irritability lockdown Mental mental health mental health. Participants Perspective Prevalence Qualitative regression analysis Research worsened [DOI] 10.1016/j.jpsychires.2022.09.001 PMC 바로가기
Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and ThailandArticle Published on 2022-11-012022-11-15 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome Affect Africa Antibody Response Antigen collected coronavirus coronavirus coronavirus disease Coronaviruses country COVID-19 COVID-19 pandemic distribution Endemic HIV-1 human SARS-CoV-2 IgG response immune response Kenya less Middle East monoclonal antibody much higher Nigeria nucleocapsid protein participant Participants populations Profiling Protein respiratory infections respiratory syndrome coronavirus response SARS SARS-CoV-1 SARS-CoV-2 SARS-CoV-2 spike screened Serosurvey serum and plasma severe acute respiratory syndrome coronavirus 2 significantly more subunit tested Thailand the receptor-binding domain Uganda Vaccine viruses zoonoses zoonoses. [DOI] 10.3201/eid2811.221041 PMC 바로가기
Concordance of SARS-CoV-2 Antibody Results during a Period of Low PrevalenceArticle Published on 2022-10-262022-11-15 Journal: mSphere [Category] COVID19(2023년), SARS, 진단, [키워드] 95% confidence interval Abbott acute respiratory syndrome Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG Antigen antigens Architect assays CDC collected combinations Concentration Concordance contributed coronavirus coronavirus disease COVID-19 Elecsy ELISA enzyme-linked immunosorbent evaluate False positivity first test Frequency IgG IgG antibodies immunoassay immunoassays Immunoglobulin individual investigated low prevalence nucleocapsid nucleocapsid protein pandemic participant Participants performed Period positive positive result Prevalence produced proportion quantified Research Result Roche SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 IgG antibody sequential test sera serological test seropositive specimen Spike protein spike protein. subset Support target tested the SARS-CoV-2 The United States Vaccine vaccine availability [DOI] 10.1128/msphere.00257-22 PMC 바로가기